NCT06653400View on ClinicalTrials.gov

Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy

PHASE1RecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

February 27, 2025

Primary Completion Date

September 1, 2025

Study Completion Date

September 1, 2025

Conditions
Abnormal Uterine BleedingAnalgesiaParacervical Block
Interventions
PROCEDURE

paracervical block

paracervical block with office hysteroscopy

DRUG

Lidocaine

Dosage: 20 mL of 1% lidocaine

DRUG

ketorolac

Dosage: 2 mL (30 mg) of ketorolac

Trial Locations (1)

10029

RECRUITING

Mount Sinai, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER